EMBC Stock Analysis: Buy, Sell, or Hold?
EMBC - Embecta Corp. Common Stock
$3.35
-0.01 (-0.30%)
▼
5d:
+7.72%
30d:
-4.01%
90d:
-61.89%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 14, 2026
Get Alerted When EMBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EMBC shows positive signals but monitor for confirmation. Market pricing in 14.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: EMBC shows positive signals but monitor for confirmation. Market pricing in 14.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.44
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$4.62
27.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EMBC is currently trading at $3.35, which is considered slightly high relative to its 30-day fair value range of $3.12 to $3.38. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.9) compared to its historical average (3.1). Remarkably, the market is currently pricing in an annual earnings decline of 14.7% over the next few years. This pessimistic expectation contrasts with the company's recent 82.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, EMBC is in a strong downtrend. Immediate support is located at $3.01, while resistance sits at $3.50.
Market Sentiment: EMBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+19.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EMBC is in a strong downtrend. Immediate support is located at $3.01, while resistance sits at $3.50.
Market Sentiment: EMBC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+19.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.12 -
$3.38
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($4.00)
Trading Range Analysis
30-Day Trading Range
$3.12 -
$3.38
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.01
Resistance Level
$3.50
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.93
Wall Street Target
$4.00
(+19.4%)
Revenue Growth (YoY)
-14.4%
Earnings Growth (YoY)
82.7%
Profit Margin
10.7%
Valuation Discount vs History
-14.7% cheaper
PE vs Historical
1.9 vs 3.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.7%
(market-implied from PE analysis)
1-Year Target
$3.02
(-10%)
2-Year Target
$2.71
(-19%)
3-Year Target
$2.44
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$3.93
(+17%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.3%)
$49.43
(+1376%)
Base:
(SPY PE: 1.9, Growth: 9.3%)
$4.37
(+30%)
Bear:
(PE: 1.6, Growth: 9.3%)
$3.71
(+11%)
📈
Valuation based on Current Earnings
Trailing PE: 1.76 | Current EPS (TTM): $1.89
Bull Case
$3.37
(+1%)
Analyst growth -7.9%, PE expands to 1.9
Base Case
$3.06
(-9%)
Market implied -7.9%, PE stable at 1.8
Bear Case
$2.26
(-33%)
Severe decline -20.0%, PE contracts to 1.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.9 to 3.1
Stabilization Target:
$5.39
(+61.0%)
PE Expansion Potential:
+61.0%
Share & Embed Analysis
Last updated: July 02, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EMBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
